Reduced dosing frequency of immune checkpoint inhibitors raises survival concerns in advanced cancer

Equitable HPV vaccination for all

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer

Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy

Amivantamab plus pembrolizumab and carboplatin in R/M HNSCC: Evaluating improved response and survival vs chemo

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer

Amivantamab in HPV-unrelated mHNSCC gives high response rates after immunotherapy and chemo

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Rilvegostomig clears ctDNA and delays recurrence in high-risk head and neck cancer

Oral cancer prevention through community counselling in a tribal population

Reducing cancer burden through prevention

Raising awareness and increasing HPV vaccination coverage in Kazakhstan